Principal Investigator
Bradley Gampel
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241033
Clinical Trial Summary
Evaluation of Digoxin for Relapsed non-WNT, non-SHH Medulloblastoma (Phase 2 Study)
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647